JPMorgan Downgrades Medtronic (MDT) to Neutral
JPMorgan downgraded Medtronic, Inc. (NYSE: MDT) from Overweight to Neutral with a price target of $64.00 (from $69.00).
Shares of Medtronic, Inc. closed at $58.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham & Company Downgrades Zimmer Holdings (ZMH) to Buy
- Mednax (MD) PT Raised to $80 at Jefferies
- UPDATE: Cowen Downgrades Advanced Emissions Solutions (ADES) to Market Perform
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!